These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6328985)

  • 21. Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.
    Stumpe KO; Overlack A; Kolloch R; Schreyer S
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):121S-126S. PubMed ID: 6291563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of captopril on renal vascular tone in patients with essential hypertension.
    Mimran A; Brunner HR; Turini GA; Waeber B; Brunner D
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():421s-423s. PubMed ID: 232029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of moderate to severe hypertensive patients with an orally active converting-enzyme inhibitor.
    Prins EJ; Donker AJ; Hoorntje SJ; Leenen FH; van der Hem GK
    Proc Eur Dial Transplant Assoc; 1979; 16():603-9. PubMed ID: 232914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal and uteroplacental hemodynamic effects of chronic captopril in the hypertensive, term-pregnant rat.
    Mabie WC; Ahokas RA; Sibai BM
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1861-7. PubMed ID: 2256496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of angiotensin-converting enzyme inhibition by captopril on cardiac output, coronary blood flow, and systemic arterial blood pressure in the intact and in the bilaterally nephrectomized rabbit.
    Ohmae M; Rabkin SW; Fung HY
    J Cardiovasc Pharmacol; 1981; 3(5):1060-7. PubMed ID: 6168851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilation.
    Kiowski W; van Brummelen P; Hulthén L; Amann FW; Bühler FR
    Clin Pharmacol Ther; 1982 Jun; 31(6):677-84. PubMed ID: 7042175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
    Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
    Drexler H; Faude F; Winterer H; Wollschläger H; Freudenberg N; Just H
    Z Kardiol; 1987 Aug; 76(8):507-13. PubMed ID: 3314215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
    Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
    [No Abstract]   [Full Text] [Related]  

  • 31. Haemodynamic changes in peripheral arterial circulation during antihypertensive treatment with captopril, methyldopa and indapamide.
    Ferrara LA; Rubba P; Iannuzzi A; Fasano ML
    Int J Clin Pharmacol Res; 1984; 4(5):389-93. PubMed ID: 6394516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and chronic systemic and pulmonary hemodynamic effects of angiotensin converting enzyme inhibition with captopril in hypertensive patients.
    Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
    Am J Cardiol; 1980 Aug; 46(2):295-300. PubMed ID: 6250392
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
    Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
    Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin converting enzyme inhibition has no effect on blood pressure and splanchnic perfusion after cardiac surgery.
    Parviainen I; Rantala A; Ruokonen E; Tenhunen J; Takala J
    J Crit Care; 1998 Jun; 13(2):73-80. PubMed ID: 9627274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
    Stanek B; Silberbauer K
    Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
    Waeber B; Brunner HR; Wauters JP; Gavras H
    Adv Nephrol Necker Hosp; 1981; 10():111-33. PubMed ID: 6267906
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of extrarenal and intrarenal converting enzyme inhibition in renal vasodilator response to intravenous captopril.
    Wong PC; Zimmerman BG
    Life Sci; 1980 Oct; 27(14):1291-7. PubMed ID: 6255273
    [No Abstract]   [Full Text] [Related]  

  • 39. Reflex control of circulation and angiotensin converting enzyme inhibition in man.
    Mancia G; Giannattasio C; Grassi G; Morganti A; Zanchetti A
    J Hypertens Suppl; 1988 Dec; 6(3):S45-9. PubMed ID: 3066877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
    Overlack A; Stumpe KO; Heck I; Krück F
    Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.